Skip to main content

Table 1 Baseline characteristics of patients analyzed

From: Efficacy and tolerability of quetiapine versus haloperidol in first-episode schizophrenia: a randomized clinical trial

  Haloperidol (n = 33) Quetiapine (n = 40) p value
Age (years ± SD) 30.76 ± 3.93 31.29 ± 3.42 0.5396
Sex (M/F) 21/12 25/15 0.92
Duration of illness (months ± SD) 4.82 ± 1.62 5.03 ± 2.14 0.6438
Marital status (unmarried/married) 19/14 23/17 0.994
Employment status (unemployed/employed) 22/11 28/12 0.76
Education (above/below secondary education) 23/10 31/9 0.449
Income (satisfactory/unsatisfactory) 7/26 8/32 0.898
Type of schizophrenia (paranoid/non-paranoid) 24/9 32/8 0.464
  1. SD = standard deviation.